Andrea Fekete

Budapest, BU, Hungary

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

The sigma-1 receptor agonist fluvoxamine alleviates endotoxin-induced acute lung injury in mice.

The sigma-1 receptor agonist fluvoxamine alleviates endotoxin-induced acute lung injury in mice.

Journal: Frontiers in pharmacology

Published: February 26, 2026

Artificial Intelligence Helps Diagnose Oral Potentially Malignant Disorders: A Systematic Review and Meta-Analysis.

Artificial Intelligence Helps Diagnose Oral Potentially Malignant Disorders: A Systematic Review and Meta-Analysis.

Journal: JDR clinical and translational research

Published: January 21, 2026

The Sigma-1 Receptor Agonist Fluvoxamine Is Protective in Hyperglycaemia-Induced Dysfunction of Trabecular Meshwork Cells.

The Sigma-1 Receptor Agonist Fluvoxamine Is Protective in Hyperglycaemia-Induced Dysfunction of Trabecular Meshwork Cells.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: December 11, 2025

UHPLC-MS-Based Analysis of Fluvoxamine in Rabbit Aqueous Humour and Serum: Method Development and Validation.

UHPLC-MS-Based Analysis of Fluvoxamine in Rabbit Aqueous Humour and Serum: Method Development and Validation.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: December 09, 2025

Pridopidine, a Potent and Selective Therapeutic Sigma-1 Receptor (S1R) Agonist for Treating Neurodegenerative Diseases.

Pridopidine, a Potent and Selective Therapeutic Sigma-1 Receptor (S1R) Agonist for Treating Neurodegenerative Diseases.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: October 27, 2025

Novel Sigma-1 receptor agonist alleviates renal ischemic injury by targeting apoptotic and inflammatory pathways.

Novel Sigma-1 receptor agonist alleviates renal ischemic injury by targeting apoptotic and inflammatory pathways.

Journal: Scientific reports

Published: June 06, 2025

Inflammatory mechanisms contribute to long-term cognitive deficits induced by perinatal asphyxia via interleukin-1.

Inflammatory mechanisms contribute to long-term cognitive deficits induced by perinatal asphyxia via interleukin-1.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

Published: May 09, 2025

Sigma-1 Receptor as a Novel Therapeutic Target in Diabetic Kidney Disease.

Sigma-1 Receptor as a Novel Therapeutic Target in Diabetic Kidney Disease.

Journal: International journal of molecular sciences

Published: October 31, 2024

Perinatal asphyxia leads to acute kidney damage and increased renal susceptibility in adulthood.

Perinatal asphyxia leads to acute kidney damage and increased renal susceptibility in adulthood.

Journal: American journal of physiology. Renal physiology

Published: June 27, 2024

Association of SDF-1-3' Gene A Variant with Diabetic Retinopathy in the Hungarian Population.

Association of SDF-1-3' Gene A Variant with Diabetic Retinopathy in the Hungarian Population.

Journal: International journal of molecular sciences

Published: June 04, 2024

Cardioprotective and Antifibrotic Effects of Low-Dose Renin-Angiotensin-Aldosterone System Inhibitors in Type 1 Diabetic Rat Model.

Cardioprotective and Antifibrotic Effects of Low-Dose Renin-Angiotensin-Aldosterone System Inhibitors in Type 1 Diabetic Rat Model.

Journal: International journal of molecular sciences

Published: November 04, 2023

Analysis of Genetic and MRI Changes, Blood Markers, and Risk Factors in a Twin Pair Discordant of Progressive Supranuclear Palsy.

Analysis of Genetic and MRI Changes, Blood Markers, and Risk Factors in a Twin Pair Discordant of Progressive Supranuclear Palsy.

Journal: Medicina (Kaunas, Lithuania)

Published: August 24, 2023

Showing 1-12 of 46

Last Updated: 09/26/2026